Charles Linker

4.6k total citations
58 papers, 2.1k citations indexed

About

Charles Linker is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Charles Linker has authored 58 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 22 papers in Oncology and 13 papers in Genetics. Recurrent topics in Charles Linker's work include Hematopoietic Stem Cell Transplantation (22 papers), Acute Myeloid Leukemia Research (20 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Charles Linker is often cited by papers focused on Hematopoietic Stem Cell Transplantation (22 papers), Acute Myeloid Leukemia Research (20 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Charles Linker collaborates with scholars based in United States, Canada and Israel. Charles Linker's co-authors include Curt A. Ries, Lloyd E. Damon, Michael W. DeGregorio, William M. F. Lee, Richard A. Jacobs, Richard M. Stone, Richard A. Larson, David C. Price, Robert E. Goldsby and Randall A. Hawkins and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

In The Last Decade

Charles Linker

57 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles Linker United States	23	944	657	451	339	337	58	2.1k
Louis Letendre United States	25	1.1k 1.2×	563 0.9×	294 0.7×	399 1.2×	490 1.5×	76	2.1k
Patrick Lutz France	26	492 0.5×	490 0.7×	462 1.0×	326 1.0×	472 1.4×	62	2.3k
Kyoo‐Hyung Lee South Korea	29	1.6k 1.7×	733 1.1×	433 1.0×	498 1.5×	416 1.2×	168	2.6k
M Carotenuto Italy	26	1.1k 1.1×	680 1.0×	252 0.6×	542 1.6×	609 1.8×	81	2.2k
M Kalaycio United States	24	980 1.0×	626 1.0×	265 0.6×	276 0.8×	307 0.9×	76	1.8k
Jaime Sanz Spain	27	1.6k 1.7×	791 1.2×	418 0.9×	460 1.4×	356 1.1×	191	2.5k
H. Wandt Germany	21	683 0.7×	596 0.9×	266 0.6×	134 0.4×	382 1.1×	48	1.9k
Edward Kanfer United Kingdom	26	1.1k 1.2×	477 0.7×	250 0.6×	416 1.2×	394 1.2×	55	1.8k
Nadežda Basara Germany	23	1.4k 1.4×	520 0.8×	610 1.4×	420 1.2×	312 0.9×	70	2.1k
Gunnar Öberg Sweden	27	1.3k 1.4×	453 0.7×	279 0.6×	313 0.9×	484 1.4×	59	2.1k

Countries citing papers authored by Charles Linker

Since Specialization

Citations

This map shows the geographic impact of Charles Linker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Linker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Linker more than expected).

Fields of papers citing papers by Charles Linker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Linker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Linker. The network helps show where Charles Linker may publish in the future.

Co-authorship network of co-authors of Charles Linker

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Linker. A scholar is included among the top collaborators of Charles Linker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Linker. Charles Linker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mannis, Gabriel N., Charalambos Andreadis, Aaron C. Logan, et al.. (2015). A Phase I Study of Targeted, Dose-Escalated Intravenous Busulfan in Combination With Etoposide as Myeloablative Therapy for Autologous Stem Cell Transplantation in Acute Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 15(6). 377–383. 2 indexed citations

Beumer, Jan H., Kouros Owzar, Lionel D. Lewis, et al.. (2014). Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103). Cancer Chemotherapy and Pharmacology. 74(5). 927–938. 17 indexed citations

Shea, Thomas C., Jeffrey L. Johnson, Peter Westervelt, et al.. (2011). Reduced-Intensity Allogeneic Transplantation Provides High Event-Free and Overall Survival in Patients with Advanced Indolent B Cell Malignancies: CALGB 109901. Biology of Blood and Marrow Transplantation. 17(9). 1395–1403. 46 indexed citations

Keever-Taylor, Carolyn A., Steven M. Devine, Robert J. Soiffer, et al.. (2011). Characteristics of CliniMACS® System CD34-Enriched T Cell-Depleted Grafts in a Multicenter Trial for Acute Myeloid Leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0303. Biology of Blood and Marrow Transplantation. 18(5). 690–697. 49 indexed citations

Devine, Steven M., Shelly Carter, Robert J. Soiffer, et al.. (2011). Low Risk of Chronic Graft-versus-Host Disease and Relapse Associated with T Cell–Depleted Peripheral Blood Stem Cell Transplantation for Acute Myelogenous Leukemia in First Remission: Results of the Blood and Marrow Transplant Clinical Trials Network Protocol 0303. Biology of Blood and Marrow Transplantation. 17(9). 1343–1351. 104 indexed citations

Stone, Richard M., Kathleen Donohue, Wendy Stock, et al.. (2008). A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804. Cancer Chemotherapy and Pharmacology. 63(5). 859–864. 28 indexed citations

Linker, Charles. (2007). The role of autologous transplantation for acute myeloid leukemia in first and second remission. Best Practice & Research Clinical Haematology. 20(1). 77–84. 9 indexed citations

FitzGerald, Paul A., Robert E. Goldsby, John P. Huberty, et al.. (2006). Malignant Pheochromocytomas and Paragangliomas. Annals of the New York Academy of Sciences. 1073(1). 465–490. 95 indexed citations

Damon, Lloyd E., et al.. (2005). High-Dose Etoposide, Thiotepa, and Dose-Adjusted Carboplatin (TVCa) With Autologous Hematopoietic Stem Cell Rescue as Treatment of Relapsed or Refractory Germ Cell Cancer. American Journal of Clinical Oncology. 28(2). 130–137. 3 indexed citations

10.

Sher, Dorie, Jeffrey L. Johnson, Michael A. Caligiuri, et al.. (2004). Eradication of Minimal Residual Disease during Treatment of Mantle Cell Lymphoma: CALGB 59909.. Blood. 104(11). 1652–1652. 2 indexed citations

11.

Damon, Lloyd E., Laura Johnston, Curt A. Ries, et al.. (2004). Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule. Cancer Chemotherapy and Pharmacology. 53(6). 468–474. 5 indexed citations

12.

Martin, Thomas G., Ryan B. O’Malley, Neal Fischbach, et al.. (2004). Voriconazole Is Safe and Effective as Prophylactic Antifungal Therapy Following Allogeneic Transplantation.. Blood. 104(11). 5094–5094.

13.

Linker, Charles, Paolo Anderlini, Roger H. Herzig, et al.. (2003). Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation. Biology of Blood and Marrow Transplantation. 9(6). 405–413. 24 indexed citations

14.

Miller, Carole B., Philip A. Rowlings, Mei‐Jie Zhang, et al.. (2001). The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia. Experimental Hematology. 29(11). 1336–1346. 37 indexed citations

15.

Martin, Thomas G. & Charles Linker. (2001). Autologous Stem Cell Transplantation for Acute Lymphocytic Leukemia in Adults. Hematology/Oncology Clinics of North America. 15(1). 121–143. 9 indexed citations

16.

Linker, Charles. (2000). Thrombopoietin in the treatment of acute myeloid leukemia and in stem-cell transplantation. Seminars in Hematology. 37(2 Suppl 4). 35–40. 8 indexed citations

17.

Nash, Richard A., Razelle Kurzrock, John F. DiPersio, et al.. (2000). A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation. 6(1). 25–34. 67 indexed citations

18.

Linker, Charles, Curt A. Ries, Lloyd E. Damon, et al.. (2000). Autologous stem cell transplantation for acute myeloid leukemia in first remission. Biology of Blood and Marrow Transplantation. 6(1). 50–57. 45 indexed citations

19.

Gale, Robert Peter, Rolla Edward Park, Robert W. Dubois, et al.. (1999). Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission. Leukemia Research. 23(8). 709–718. 10 indexed citations

20.

Gale, Robert Peter, Rolla Edward Park, Robert W. Dubois, et al.. (1998). Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission. Leukemia Research. 22(11). 973–981. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact